このエントリーをはてなブックマークに追加


ID 60467
FullText URL
fulltext.pdf 3.89 MB
Author
Yoshida, Satoru Department of Regenerative Medicine and Stem Cell Biology, Fujita Health University School of Medicine
Okura, Hanayuki Department of Regenerative Medicine Support Promotion Facility, Center for Research Promotion and Support, Fujita Health University
Suga, Hidetaka Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Soen, Mika Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Kawaguchi, Yohei Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Kurimoto, Junki Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Miyata, Takashi Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Takagi, Hiroshi Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Arima, Hiroshi Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine
Fujikawa, Tatsuya Department of General Internal Medicine, Mitoyo General Hospital
Otsuka, Fumio Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Matsuyama, Akifumi Department of Regenerative Medicine and Stem Cell Biology, Fujita Health University School of Medicine
Abstract
Four disease-specific induced pluripotent stem cell (iPSC) lines were respectively derived from peripheral blood mononuclear cells of two affected individuals in a family affected by familial neurohypophyseal diabetes insipidus carrying the c.314G>C mutation. The expression of pluripotency markers (NANOG, OCT4, and SOX2), maintenance of a normal karyotype, absence of episomal vectors used for iPSC generation, and presence of the original pathogenic mutation were confirmed for each iPSC line. The ability to differentiate into three germ layers was confirmed by a teratoma formation assay. These iPSC lines can help in disease recapitulation in vitro using organoids and elucidation of disease mechanisms.
Published Date
2020-10
Publication Title
Stem Cell Research
Volume
volume48
Publisher
Elsevier
Start Page
101960
ISSN
1873-5061
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2020 The Authors
File Version
publisher
PubMed ID
DOI
Related Url
isVersionOf https://doi.org/10.1016/j.scr.2020.101960
License
https://creativecommons.org/licenses/by/4.0/
Open Access (Publisher)
OA
Open Archive (publisher)
Non-OpenArchive